In estrogen receptor positive breast cancer cells, resveratrol mediates apoptotic cell death via Bcl-2 downregulation that is independent of cytochrome c release and cleavage of caspases 3/8 and PARP [117]. This evidence concerns the gene BCL2 and breast cancer.